Channel Expansion Expand distribution through pharmacy networks in Australia, the UK, and Europe by leveraging 2San's presence at industry events and partnerships with Independent Pharmacies Australia and other distributors to onboard independent and chain pharmacies for home-testing across Infection, Drugs of Abuse, Health and Wellness, and Family Planning.

Workplace Partnerships Target corporate wellness and employee testing programs by offering at-home diagnostic kits as part of return-to-work and preventive health initiatives, with potential integrations to HR or benefits platforms to drive volume among mid-market employers.

Safety Market Leverage SafeSip+ Drink Test Stickers and Breath Alcohol Test to enter hospitality venues, universities, events, and safety retailers, creating B2B safety testing opportunities beyond clinical channels.

Digital Platform Capitalize on the 2023 app launch and digital stack to enable partner integrations with telehealth and EHR systems, driving data capture, compliance, and guided at-home testing to boost repeat purchases.

Global Partnerships Build on existing distribution and trade show momentum by pursuing additional distributors and pharmacy chains to accelerate geographic reach in Europe, UK, and other markets, expanding 2San's global self-testing footprint.